Skip to main content

Genetic aberrations of the K-ras proto-oncogene in bladder cancer
in relation to pesticide exposure

Research Authors
Diaa A. Hameed1 & Heba A. Yassa2 & Michael N. Agban3 & Randa T. Hanna4 & Ahmed M. Elderwy1 &
Mohamed A. Zwaita1
Research Department
Research Journal
Environmental Science and Pollution Research
Research Publisher
Heba A. Yassa
Research Rank
1
Research Vol
https://doi.org/10.1007/s11356-018-1840-6
Research Website
pubmed, google schoolar
Research Year
2018
Research_Pages
NULL
Research Abstract

In Egypt, bladder cancer is one of the most popular cancer, accounting for 31% of all cancer cases. It ranks first in males about
16.2% of male cancer. The incidence in rural areas among males is near 32 per 100,000. The exact etiology of bladder cancer is
still unknown; K-ras gene is known as a critical DNA target for chemical carcinogens as a pesticide. Some occupational hazard
exposure is thought to be directly genotoxic, while others might enhance the mutagenicity and carcinogenicity of directly acting
genotoxic agents. Analysis of the relationship between pesticide exposure and mutation in the K-ras gene in human bladder
cancer. One hundred patients were diagnosed with bladder cancer and one hundred controls attended the outpatient clinic; after
taking consent and filling a questionnaire for age, sex, occupation and pesticide exposure, surgically resected specimens were
collected and the samples were used to determine the k-ras mutation. Blood samples were taken to analyze the level of
acetylcholinesterase enzyme and level of P53. The present study indicated that pesticide exposure may play a great role in
malignant transformation of the bladder cells through mutation in the K-ras gene; there was a significant correlation between
the acetylcholinesterase enzyme level and k-ras mutation (p < 0.001). The results revealed that the level of P53 was significantly
high in comparison with the control group (p < 0.001). These findings give an alarm to decrease the amount of pesticides used in
our area; also, p53 may be used as an indicator to bladder cancer.